GDC-0941 activates integrin linked kinase (ILK) expression to cause resistance to GDC-0941 in breast cancer by the tumor necrosis factor (TNF)-α signaling pathway

Breast cancer is characterized by high morbidity and mortality. GDC-0941 is a PI3K inhibitor with oncogenic effects in breast cancer. However, certain breast cancer cells are insensitive to GDC-0941. Hence, the mechanism of GDC-0941 in breast cancer resistance was investigated in this study. Breast...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Haifeng, Cheng, Mingming, Gao, Pengcheng, Zhang, Xiangzhong, Li, Ganggang, Wang, Liting, Qin, Long, Li, Hongrui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9208486/
https://www.ncbi.nlm.nih.gov/pubmed/35477364
http://dx.doi.org/10.1080/21655979.2022.2066758

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9208486/
https://www.ncbi.nlm.nih.gov/pubmed/35477364
http://dx.doi.org/10.1080/21655979.2022.2066758

Ejemplares similares